DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,071 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $812,013 | +0.1% | 3,250 | 0.0% | 0.22% | 0.0% |
| Q1 2024 | $811,590 | +7.9% | 3,250 | 0.0% | 0.22% | -4.9% |
| Q4 2023 | $751,855 | -6.8% | 3,250 | 0.0% | 0.23% | -15.7% |
| Q3 2023 | $806,325 | +46.6% | 3,250 | +41.8% | 0.27% | +49.7% |
| Q2 2023 | $550,080 | -4.8% | 2,292 | 0.0% | 0.18% | -9.1% |
| Q1 2023 | $577,676 | -5.0% | 2,292 | 0.0% | 0.20% | -11.3% |
| Q4 2022 | $608,343 | +2.8% | 2,292 | 0.0% | 0.22% | -1.3% |
| Q3 2022 | $592,000 | +1.9% | 2,292 | 0.0% | 0.22% | +9.2% |
| Q2 2022 | $581,000 | -13.5% | 2,292 | 0.0% | 0.21% | +21.2% |
| Q1 2022 | $672,000 | -9.2% | 2,292 | +1.9% | 0.17% | -5.6% |
| Q4 2021 | $740,000 | +8.2% | 2,250 | 0.0% | 0.18% | +1.1% |
| Q3 2021 | $684,000 | +13.4% | 2,250 | 0.0% | 0.18% | +20.3% |
| Q2 2021 | $603,000 | +4.7% | 2,250 | 0.0% | 0.15% | +0.7% |
| Q1 2021 | $576,000 | +15.2% | 2,250 | 0.0% | 0.15% | -49.0% |
| Q4 2020 | $500,000 | – | 2,250 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |